VitaNova Life Sciences (VNOV) Net Cash Flow Growth (3y) (2021 - 2026)

VitaNova Life Sciences (VNOV) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	NCF Growth (3y) (Qtr)
1	Mckesson	102.57 Bn	97.41 Bn	3.69 Bn	37.26%
2	Cencora	61.35 Bn	58.53 Bn	3.61 Bn	83.11%
3	Cardinal Health	54.15 Bn	49.30 Bn	2.56 Bn	141.98%
4	Henry Schein	10.05 Bn	9.89 Bn	1.10 Bn	-6.47%
5	Akso Health	671.90 Mn	671.70 Mn	-	-
6	Edap Tms	154.62 Mn	133.07 Mn	7.34 Mn	47.18%
7	Accendra Health	90.69 Mn	83.04 Mn	263.41 Mn	-51.20%
8	111	31.31 Mn	-27.44 Mn	18.18 Mn	-23.79%
9	Cosmos Health	13.28 Mn	10.84 Mn	1.51 Mn	26.38%
10	VitaNova Life Sciences	11.51 Mn	9.91 Mn	264,662.00	474.33%

Download Data